Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Elara MD vs Lemonaid Health

Elara MD
Graded #466

Higher grade

vs+2.299999999999997
Lemonaid Health
Graded #488

Lower grade

The verdict

Elara MD takes it — 53.5/100 to 51.2/100.

Elara MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Elara MD is a weight-loss and wellness telehealth platform offering weekly injectable GLP-1 therapy alongside a peptide menu (NAD+, sermorelin, glutathione).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueElara MD +20
40
20
Dose & formulationElara MD +2
54
52
Clinical oversightLemonaid Health +11
63
74
Labs & monitoringLemonaid Health +1
52
53
FulfillmentLemonaid Health +15
66
81
Contract termsElara MD +14
55
41
Elara MD · left barLemonaid Health · right bar

The numbers

MetricElara MDLemonaid Health
WeighScore53.5/10051.2/100
GradeCC
Scorecard rank#466#488
Semaglutide$249/mo (0.2 mg dose, compounded)$348/mo (starting dose, plus a separate fee, compounded)
Tirzepatide$349/mo (2.0 mg dose, compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Elara MD

Graded #466 · C

Strengths

  • Dose-banded monthly pricing published on-site ($249–$649/mo across tiers)
  • Both a semaglutide-range and a tirzepatide-range (GLP-1/GIP) option, plus microdosing
  • Medication included in the monthly price with free fast shipping when prescribed
  • Broad reach claimed (over 40 states)

Where it loses points

  • Molecules not named on-site (only 'Personalized GLP-1') — compounded status is inferred
  • No FDA compounded-medication disclaimer published
  • No named compounding pharmacy partner — prescriptions are patient-directed
  • LegitScript certification, medical director, and full state list not disclosed
  • Pricier than several compounded competitors
Lemonaid Health

Graded #488 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard